Matt Woll

Matt Woll

Company: PTC Therapeutics

Job title: Vice President, Chemistry


Early Discovery Lessons Learned Along the Path to Risdiplam 9:30 am

With the discovery and commercial success of Evrysdi® (risdiplam) in treating SZA, the use of small molecules to influence pre-mRNA splicing has become a fertile ground for drug discovery With hindsight vision, some of the key determinants to successful identification of risdiplam precursors will be discussed, including the importance of a sensitive screening assay and…Read more

day: Day 1 AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.